“Burning%2Bmouth%2Bsyndrome”的搜索结果，显示 91-100 项，共有 5448 项

1. 神经科- 临床试验- 妙佑医疗国际

   and/or disease duration, and whether there is a left-right difference in the density of a-syn pathology. Specific Aim 2. Determine, with a second SMG biopsy in ...

2. 内分泌科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate whether or not semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 ...

3. 神经科- 临床试验- 妙佑医疗国际

   This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). ... Go to page 22 · Go to page 33 · Go to ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study ...

5. 神经科- 临床试验- 妙佑医疗国际

   This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). ... Go to page 22 · Go to page 33 · Go to ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial. A Study ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A ...

8. 神经科- 临床试验- 妙佑医疗国际

   Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization ...

9. 神经科- 临床试验- 妙佑医疗国际

   ... disease following an attempt to perform definitive treatment (including surgery, radiation and/or adjuvant or neoadjuvant chemotherapy). Cohort 2 includes ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial. A Study ...